Given that the acquisition of chemoresistance in NSCLC is partly attributed to enhanced antiapoptotic activity [5, 30], we hypothesize that USP15‐induced chemoresistance may be driven by the inhibition of apoptosis. The gene discussed is USP15; the disease is non-small cell lung carcinoma.